Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

1.

Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.

Wires ES, Alvarez D, Dobrowolski C, Wang Y, Morales M, Karn J, Harvey BK.

J Neurovirol. 2012 Oct;18(5):400-10. doi: 10.1007/s13365-012-0103-4. Epub 2012 May 22.

PMID:
22618514
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.

J Virol. 1993 May;67(5):2853-61.

PMID:
8386279
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways.

Leghmari K, Bennasser Y, Bahraoui E.

Eur J Cell Biol. 2008 Dec;87(12):947-62. doi: 10.1016/j.ejcb.2008.06.005. Epub 2008 Aug 29.

PMID:
18760861
[PubMed - indexed for MEDLINE]
7.

T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.

Lemieux AM, Paré ME, Audet B, Legault E, Lefort S, Boucher N, Landry S, van Opijnen T, Berkhout B, Naghavi MH, Tremblay MJ, Barbeau B.

J Biol Chem. 2004 Dec 17;279(51):52949-60. Epub 2004 Oct 1.

PMID:
15466412
[PubMed - indexed for MEDLINE]
Free Article
8.

The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.

Gómez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcamí J, López-Cabrera M.

J Biol Chem. 2001 Sep 21;276(38):35435-43. Epub 2001 Jul 16.

PMID:
11457829
[PubMed - indexed for MEDLINE]
Free Article
9.

Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.

Kelly GD, Morris CB, Offermann MK.

Virology. 1999 Oct 10;263(1):128-38.

PMID:
10544088
[PubMed - indexed for MEDLINE]
Free Article
10.

Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.

McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.

Virology. 2000 Sep 1;274(2):262-77.

PMID:
10964770
[PubMed - indexed for MEDLINE]
Free Article
11.

B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity.

Iordanskiy S, Iordanskaya T, Quivy V, Van Lint C, Bukrinsky M.

Virology. 2002 Oct 10;302(1):195-206.

PMID:
12429528
[PubMed - indexed for MEDLINE]
Free Article
12.

Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.

Biswas DK, Ahlers CM, Dezube BJ, Pardee AB.

Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11044-8.

PMID:
8248210
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.

Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.

Virology. 1997 Aug 18;235(1):48-64.

PMID:
9300036
[PubMed - indexed for MEDLINE]
Free Article
14.

ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB.

Yang X, Chen Y, Gabuzda D.

J Biol Chem. 1999 Sep 24;274(39):27981-8.

PMID:
10488148
[PubMed - indexed for MEDLINE]
Free Article
15.

EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.

Zhang HS, Wu TC, Sang WW, Ruan Z.

Life Sci. 2012 May 22;90(19-20):747-54. doi: 10.1016/j.lfs.2012.03.013. Epub 2012 Mar 26.

PMID:
22480519
[PubMed - indexed for MEDLINE]
16.

Alpha-lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants.

Merin JP, Matsuyama M, Kira T, Baba M, Okamoto T.

FEBS Lett. 1996 Sep 23;394(1):9-13.

PMID:
8925935
[PubMed - indexed for MEDLINE]
Free Article
17.

Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells.

Kiebala M, Maggirwar SB.

PLoS One. 2011 Apr 8;6(4):e18633. doi: 10.1371/journal.pone.0018633.

PMID:
21494611
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Association of p65 and C/EBPbeta with HIV-1 LTR modulates transcription of the viral promoter.

Mukerjee R, Sawaya BE, Khalili K, Amini S.

J Cell Biochem. 2007 Apr 1;100(5):1210-6.

PMID:
17031851
[PubMed - indexed for MEDLINE]
19.

Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.

Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.

J Virol. 1996 Sep;70(9):5777-85.

PMID:
8709193
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.

Barbeau B, Bernier R, Dumais N, Briand G, Olivier M, Faure R, Posner BI, Tremblay M.

J Biol Chem. 1997 May 16;272(20):12968-77.

PMID:
9148903
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk